許正宇:持續檢視和優化「中概股」上市規管制度
財經事務及庫務局局長許正宇表示,對於希望選擇香港市場的「中概股」發行人,當局已做好準備,把握國際金融中心的制度優勢和「一國兩制」下的獨特有利位置,吸納優質「中概股」在港上市,豐富市場選擇,增加市場流動性。
他指,據市場資料,目前有超過200隻「中概股」在美國上市。截至今年3月,有19家「中概股」發行人已透過第二上市或雙重主要上市回流本港,其總市值佔所有於美國上市的「中概股」超過七成。港交所(00388.HK)和證監會會繼續根據已優化的上市規則審批有意回流「中概股」的上市申請。
他表示,證監會會定期與港交所討論與上市有關的事宜,又指雙重存檔制度的機制現時運作暢順,政府會與證監會和港交所保持溝通,持續檢視相關上市規管制度的落實情況,並適時予以優化。(ca/a)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.